US 9603820
Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma
granted A61KA61K31/196A61P
Quick answer
US patent 9603820 (Ornithine aminotransferase inhibition with GABA analogues for treatment of hepatocellular carcinoma) held by Northwestern University expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/196, A61P, A61P1/16, A61P35/00